New York State Common Retirement Fund Acquires Shares of 407,459 Stevanato Group S.p.A. (NYSE:STVN)

New York State Common Retirement Fund purchased a new stake in Stevanato Group S.p.A. (NYSE:STVN - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 407,459 shares of the company's stock, valued at approximately $8,879,000. New York State Common Retirement Fund owned about 0.13% of Stevanato Group as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently added to or reduced their stakes in the company. Peregrine Capital Management LLC boosted its stake in shares of Stevanato Group by 1.9% during the 4th quarter. Peregrine Capital Management LLC now owns 366,078 shares of the company's stock worth $7,977,000 after acquiring an additional 6,661 shares in the last quarter. Truist Financial Corp boosted its stake in shares of Stevanato Group by 4.2% during the 4th quarter. Truist Financial Corp now owns 26,900 shares of the company's stock worth $586,000 after acquiring an additional 1,073 shares in the last quarter. Conestoga Capital Advisors LLC boosted its stake in shares of Stevanato Group by 5.3% during the 4th quarter. Conestoga Capital Advisors LLC now owns 8,082,996 shares of the company's stock worth $176,128,000 after acquiring an additional 407,086 shares in the last quarter. Jennison Associates LLC purchased a new stake in shares of Stevanato Group during the 4th quarter worth about $20,239,000. Finally, SG Americas Securities LLC boosted its stake in shares of Stevanato Group by 18.2% during the 4th quarter. SG Americas Securities LLC now owns 15,546 shares of the company's stock worth $339,000 after acquiring an additional 2,389 shares in the last quarter.

Remove Ads

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the stock. Wolfe Research began coverage on shares of Stevanato Group in a research note on Friday, December 13th. They set an "outperform" rating and a $28.00 target price on the stock. Morgan Stanley reaffirmed an "equal weight" rating and issued a $23.00 price target (down from $24.00) on shares of Stevanato Group in a research note on Tuesday, December 3rd. Finally, Bank of America raised their price target on shares of Stevanato Group from $24.00 to $26.00 and gave the company a "buy" rating in a research note on Friday, December 13th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of €28.60 ($29.79).

Stevanato Group Price Performance

Stevanato Group stock traded down €1.04 ($1.08) during midday trading on Friday, reaching €18.44 ($19.21). The company had a trading volume of 359,700 shares, compared to its average volume of 317,303. The company has a market capitalization of $5.58 billion, a P/E ratio of 39.23, a P/E/G ratio of 7.18 and a beta of 0.56. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21. Stevanato Group S.p.A. has a 12-month low of €16.56 ($17.25) and a 12-month high of €34.00 ($35.42). The firm's fifty day simple moving average is €21.54 and its 200-day simple moving average is €20.54.

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.